Karin Jooss - Insider Trading & Ownership

Entity
Individual
Location
C/O Gritstone Oncology, Inc., 5858 Horton Street, Suite 210, Emeryville, CA
Summary
The estimated net worth of Karin Jooss is at least $621K dollars as of June 11, 2024. Karin Jooss is the EVP, Head of Research and Development of Gritstone bio, Inc. and owns shares of Gritstone bio, Inc. (GRTS) stock worth about $511K. Karin Jooss is the Director of FATE THERAPEUTICS INC and owns shares of FATE THERAPEUTICS INC (FATE) stock worth about $109K.
All Insider Reports
All Insider Reports

Ownership of Karin Jooss

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
GRTS Gritstone bio, Inc. EVP, Head of Research and Development $511K -$10.3K -1.97% May 15, 2024
FATE FATE THERAPEUTICS INC Director $109K Jun 7, 2024

Insider Transactions Reported by Karin Jooss:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.